LicianPro

BCAB stock

Bioatla Inc (BCAB) short interest & short volume · 73K shares short

Bioatla Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

BCAB short interest fell 3.5% to 73K shares in the Oct 15, 2026 report (6.3 days to cover). Daily short volume averaged 48.0% of volume over the last 20 sessions, up from 41.5% the 20 sessions before, the 71st percentile of its own 20-day averages since Sep 16, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
73K
prior 76K
% of float
—
no float on file
Days to cover
6.3
avg vol 12K
Change vs prior report
-3.5%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Aug 28)
48.1%
206K of 428K
20-day average
48.0%
prior 41.5%
Percentile vs own history
71st
192 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Aug 28, 2026

Short squeeze score (model)

Price since settlement: +53.8%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

BCAB's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · BCAB overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-08-28206,065428,13748.1%
2026-08-275,17211,06346.8%
2026-08-264,8189,83649.0%
2026-08-259,84918,95052.0%
2026-08-24116,168236,69249.1%
2026-08-2138,41355,84968.8%
2026-08-206,99510,40367.2%
2026-08-1919,66234,65056.7%
2026-08-186,32515,34941.2%
2026-08-1794,578153,85261.5%

Healthcare peers with similar quant ratings

BCAB among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

BCAB short interest FAQ

What is BCAB's short interest?

Bioatla Inc (BCAB) had 73K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does BCAB have?

6.3 days: 73K shares short divided by an average daily volume of 12K for the Oct 15, 2026 period.

Is BCAB short interest rising or falling?

BCAB short interest fell (-3.5%) from 76K to 73K shares in the Oct 15, 2026 report.

Is BCAB a short squeeze candidate?

Lician's squeeze watch scores BCAB 36 out of 100 (low) from the Oct 15, 2026 report: days to cover 15.8/25, change in short interest vs prior report 0/15, price change since settlement date 20/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of BCAB daily volume is sold short?

48.0% on average over the last 20 sessions to Aug 28, 2026 (FINRA Reg SHO daily short volume; the 71st percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was BCAB's latest FINRA short volume?

On Aug 28, 2026, cached FINRA short volume for Bioatla Inc (BCAB) was 206,065 shares, 48.1% of 428,137 total volume.

How many BCAB short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Bioatla Inc (BCAB), from Aug 17, 2026 through Aug 28, 2026.

How did BCAB short volume percent change from the prior cached session?

Cached FINRA short volume for Bioatla Inc (BCAB) moved from 46.8% on Aug 27, 2026 to 48.1% on Aug 28, 2026, up 1.3 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.